점액 제거 장치 시장

Market Overview
Mucus Clearance Devices Market size was valued at USD 582.3 million in 2022 and is estimated to reach at a compound annual growth rate (CAGR) of 5.90% over the forecast period 2023 to 2030.
Mucus clearing devices, also known as airway clearance devices, are used to help clear the lungs and airways of secretions. The secretions are typically connected to illnesses like Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Cystic Fibrosis. Mucus clearance devices loosen thick lung mucus so it can be cleared by coughing. Clearing mucus from the airways helps in reducing lung infections and improves lung function.
Market Dynamics
Rising demand from the geriatric population will be a major driver for the global mucus clearance devices market
The increasing geriatric population has led to higher respiratory diseases such as COPD, bronchitis, and cystic fibrosis. Airway clearance systems offer long-term benefits to patients suffering from excessive formation of mucus in the lungs by providing lung expansion and facilitating pulmonary mucus clearance. The geriatric population is much more susceptible to respiratory infections and diseases due to reduced immunity. The growing demand from the geriatric population is expected to boost the growth of the global mucus clearance devices market during the forecast period.
Dearth of skilled professionals is expected to restrain the global mucus clearance devices market
Over the forecast period, the dearth of skilled professionals is expected to prevent the growth of the global mucus clearance devices market. Mucus clearance procedures require highly skilled anesthetists and trained nurses. The lack of knowledge regarding the right choice of immediate treatment can adversely affect the patient's condition, increase recovery time, and surge direct and indirect expenses. The lack of skilled personnel is hampering the growth of the global mucus clearance devices market.
Technological innovations are expected to generate new opportunities for the global mucus clearance devices market
Many new technological innovations are taking place in the biomedical devices field. For example, Zephyr, a breakthrough-designated device, has been approved by the U.S. FDA for patients suffering from severe emphysema.
Stringent medico-legal regulations are expected to present challenges for the global mucus clearance devices market
Many countries globally have toughened medical regulations to protect patient rights and ensure the highest operational standards for medical devices. Companies developing and manufacturing mucus clearance devices must conform to additional regulations to get market approval. It presents challenges to the growth of the global mucus clearance devices market.
COVID-19 Impact Analysis
The COVID-19 outbreak will impact the mucus clearance devices market in the initial phase of the forecast period. There is growing clinical evidence that COVID-19 causes sustained airway dysfunction in vulnerable individuals. People with pre-existing respiratory conditions such as bronchitis and COPD are more vulnerable to COVID-19 infection and its complications. Therefore, the pandemic is expected to boost the global demand for mucus clearance devices.
Recent Developments in the Industry:
1. In April 2021, Smiths Medical has introduced the acapella choice blue vibratory PEP therapy system. Acapella is intended to help patients with Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, a lung disease with secretory problems, and atelectasis remove secretions.
2. In July 2022, Synchrony, an Israel-based startup, announced the start of clinical trials for its proprietary mucus clearance system at the Israel Sheba Medical Center.
3. In June 2022, the U.S. FDA announced the recall of Medtronics and Baxter International's mucus clearance devices, citing a high risk of injury or death.
Market Segmentation:
The scope of the report covers segmentation based on product, indication, end-user, and region. The global mucus clearance devices market is segmented by product into High-Frequency Chest Wall Oscillation (HFCWO) Devices, Oscillatory Positive Expiratory Pressure (OPEP) Devices, Mechanical Cough Assist (MCA) Devices, Intrapulmonary Percussive Ventilation (IPV) Devices, and Positive Expiratory Pressure (PEP) Devices. The global mucus clearance devices market is segmented by indication into COPD, cystic fibrosis, bronchiectasis, and others. The global mucus clearance devices market is segmented by end-user into hospitals, home care, clinics, and others. The global mucus clearance devices market is segmented by region into North America, South America, Europe, Asia-Pacific, Middle East, and Africa.
1. Hospital: Hospitals are the primary point for advanced care for patients with obstructive pulmonary diseases. Mucus clearance devices are also used to clear a patient's airways as part of preparation before lung surgery.
2. Home Care: In recent years, patients with respiratory diseases have been using various devices to help remove mucus from the airways and improve pulmonary function. The current physiotherapy devices for patients with respiratory diseases are marketed as an alternative or supplemental therapy that can encourage patients to self-administer therapy. Because they provide many benefits, such as independent application, full control of therapy, and ease of use, they appear to increase patients' compliance with daily treatment.
3. Clinics: Clinics are primary healthcare facilities that provide medical care to anyone who requires it. They were originally designed for people without insurance because their services are less expensive than those provided by traditional emergency rooms. Clinics have become an integral part of society. They offer almost everything that an ER does but at a lower cost because these clinics were designed with the idea that medical care should be available to everyone who needs it.
4. Others: Ambulatory surgery centers, also known as outpatient surgical centers, are modern medical facilities that provide same-day surgical care. They do not require hospital admissions for procedures.
Regional Classification:
According to the DataM Intelligence market research report, the global mucus clearance devices market is divided into North America, South America, Europe, Asia-Pacific, Middle East, and Africa.
A study by the center for disease control (CDC) estimated that in 2021, 44.3 percent of asthmatic children aged 18 and under said they had one or more asthma attacks in the previous year. A total of 47.2 percent of asthmatic children under five had an attack. It is further estimated that there are 350,000 to 500,000 people with bronchiectasis. COPD is a widely prevalent ailment in Mexico.
Many established companies and startups in North America are currently undertaking various innovative product developments for mucus clearance devices. Regulatory approvals have also been loosened to enable patients to access better care. For example, in January 2022, the U.S. FDA allowed the home use of AirPhysio devices for patients with chronic pulmonary ailments. The North American mucus clearance devices market is expected to register significant growth in the coming years.
Competitive Analysis:
The global market for mucus clearance devices is highly competitive and fragmented, with various established companies and startups active in the global market for mucus clearance devices. The major players adopt several growth strategies such as launching new products, patenting new technologies, collaborations and joint ventures, thereby contributing to the growth of the global mucus clearance devices market.
Major Companies:
Some key companies contributing to the global market for mucus clearance devices growth include AbbVie Inc., Smiths Group plc., VORTRAN Medical Technology, Inc., Thayer Medica, Monaghan Medical Corporation, Koninklijke Philips N.V., Baxter International, Inc., Electromed Inc., CEGLA Medizintechnik, and PARI GmbH, among others.